Copyright © Inderes 2011 - present. All rights reserved.
Log in to your Inderes Free account to see all free content on this page.
Create account

Novo Nordisk

295.50 DKK

+5.29 %

Less than 1K followers

NOVO B

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

+5.29 %
-14.78 %
-9.15 %
-1.84 %
+2.07 %
-52.30 %
-37.23 %
+34.20 %
+23,634.94 %

Novo Nordisk is a producer of insulin for diabetes treatment. In addition to the specialist expertise in diabetes, the company produces drugs for hormone treatment as well as for hemophilia and bleeding disorders. The products are found on a global market and are sold under separate brands. Novo Nordisk was founded in 1923 and is headquartered in Bagsværd, Denmark.

Read more
Market cap
1.32T DKK
Turnover
3.88B DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26.3.
2026

General meeting '26

27.3.
2026

Half year dividend

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Forum discussions
That does seem to be a genuine account: https://www.reuters.com/legal/litigation/fda-take-action-companies-marketing-illegal-copycat-drugs-fda-chief-says-2026-02-05/ The FDA has to act here, because otherwise drug development will cease if other companies can sell untested copycat...
2/6/2026, 6:59 AM
by Ränta på ränta
45
I don’t know how “legit” this official’s alleged X post is, but Hims tumbled further in the after-market. https://x.com/DrMakaryFDA/status/2019552255310020616 Novo +1.4% in the after-market. The tickets to this circus were expensive through Novo, but since they’re bought, I’ll have...
2/6/2026, 6:52 AM
by Divinesia
41
There is not something in the water in Denmark, besides the annoying levels of lime that destroys your household applies I do also follow Terry Smith’s commentary, and I do agree with him, especially with regard his views of leadership of Novo. What has most surprised me (in a negative...
yesterday
by 916
33
Hims & Hers is bringing a drug to market by bypassing the FDA approval process, so they are violating more than just some patent. If such a thing is permitted, why would anyone bother getting the drugs they develop approved by the FDA anymore?
2/6/2026, 7:32 AM
by Kari Kokkonen
32
Hims & Hers is backing off: WKZO | Everything Kalamazoo | 590 AM · 106.9 FM Hims to stop offering GLP-1 pill after FDA warned of crackdown By Anusha Shah and Amina Niasse Feb 7 (Reuters) - Online telehealth company Hims & Hers on Saturday reversed course on its launch of a $49 compounded...
17 hours ago
31
https://www.cnbc.com/amp/2026/01/09/amazon-pharmacy-starts-offering-novo-nordisks-wegovy-weight-loss-pill.html I see this as good news for both Amazon and Novo, as the Wegovy pill can be sold affordably to the Amazon Prime customer network. This does not bode well for operators like...
yesterday
by Ränta på ränta
21
I can share some insights into these patent matters from my perspective. There are many loopholes regarding what patents are applied for; it really comes down to the specific wording. It might only be a manufacturing method, as patents aren’t granted for everything. Semaglutide itself...
2/5/2026, 9:08 PM
by äspee
13
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.